An external clinical trial comparing feedback of Alera to other high end products on the market was conducted in summer 2010. Participants held a telephone up to the test devices programmed to the manufacturers’ first-fit gains, and it was noted whether feedback occurred. Although no feedback was experienced with Device C, this particular hearing instrument prescribed on average 10 dB less high frequency gain than the others. The ReSound Alera with DFS Ultra and Whistle Control™ demonstrated the lowest occurrence of feedback compared to devices with similar gain.
This means that even while engaging in the most
feedback-prone activities, such as talking on a cell
phone, hearing instrument users fitted with DFS Ultra
can enjoy state-of-the-art feedback control without sacrificing audibility or superior sound quality.